-
1
-
2
-
3
-
4
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
5
-
6
-
7
-
8
-
9
-
10
-
11
Association between Serum Uric Acid and Metabolic Syndrome in Koreans
Veröffentlicht in Journal of Korean medical science
VolltextArtikel -
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20